Michael Gattens

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Journal: Blood advances

Published: May 07, 2026

Somatic PLCG1 Mutation in a Vascular Tumor of an Infant.

Somatic PLCG1 Mutation in a Vascular Tumor of an Infant.

Journal: Pediatric blood & cancer

Published: March 10, 2026

A child with CANDLE syndrome presenting as seronegative polyarthritis following early chemotherapy.

A child with CANDLE syndrome presenting as seronegative polyarthritis following early chemotherapy.

Journal: Rheumatology (Oxford, England)

Published: November 16, 2025

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia

Published: October 06, 2025

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Journal: European journal of haematology

Published: March 17, 2023

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Journal: Thrombosis and haemostasis

Published: February 13, 2021

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.

Journal: Blood

Published: November 29, 2020

The Role of Blood and Marrow Transplantation in Treating Pediatric Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.

The Role of Blood and Marrow Transplantation in Treating Pediatric Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.

Journal: Transplantation and cellular therapy

Published: September 04, 2020

Successful Auxiliary Liver Transplant Followed by Hematopoietic Stem Cell Transplantation in X-Linked Lymphoproliferative Disease Type 1.

Successful Auxiliary Liver Transplant Followed by Hematopoietic Stem Cell Transplantation in X-Linked Lymphoproliferative Disease Type 1.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: July 06, 2020

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease.

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 21, 2020

Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiency.

Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiency.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: December 04, 2018

Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 05, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026